Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PIKA-adjuvanted recombinant SARS-CoV-2 spike protein vaccine study in healthy adults
PACTR202202526350870Phase 1Not yet recruiting
- Sponsor
- LakeShore Biopharma Co., Ltd
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial in coronavirus disease 2019 (COVID-19) (3 cohorts), sponsored by LakeShore Biopharma Co., Ltd. Planned start Feb 2022; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202202526350870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202526350870.